• Hospira (Lake Forest, Illinois) reported the introduction of the GemStar SP infusion system with GemStar Infusion Suite software, an advanced version of the GemStar pump. The GemStar SP infusion system is designed to help caregivers better incorporate patient safety best practices right at the patient's bedside. GemStar SP uses GemStar Infusion Suite software, a stand-alone PC-based application designed to enhance safe and efficient medication administration.

• Luminex (Austin, Texas) reported the commercial release of xPONENT 3.1 data acquisition software. Launched for use on Luminex 100 and Luminex 200 systems, xPONENT 3.1 includes more than 65 new features designed to benefit scientists and laboratory professionals across research and clinical diagnostic markets in simplifying laboratory workflow and increasing productivity. Luminex said it has added xPONENT 3.1 to its FDA-cleared Luminex 100 and 200 systems for use in clinical diagnostic applications.

• Neuisys Imaging System Solutions (Greensboro, North Carolina) received FDA clearance of the NeuViz 16 Multi-Slice computed tomography (CT) system. "The NeuViz 16 is a state-of-the-art CT system that provides superior performance for the price and provides the clinical benefits of routine, sub-millimeter resolution, volume imaging and low-dose protocols," said President/CEO Kim Russell. "The NeuViz 16 packs a tremendous amount of technology into a very economical footprint and is the perfect solution for diagnostic imaging centers and community hospitals that plan to upgrade from older single or multi-slice CT systems to 16-slice CT as well as a wide array of specialist physician groups considering in-office CT including urologists, gastroenterologists, pulmonologists, surgeons, and oncologists."

• Paieon (Wynnewood, Pennsylvania) reported FDA approval of its Guidance application. The Guidance application is now available as part of the second generation of the IC-PRO, an imaging workstation that supports the interventional cardiologist in all phases of the catheterization procedure. The Guidance application is a navigation system that is used in interventional cardiology procedures. Paieon says the Guidance application allows the user to take advantage of the existing captured images and add a new dimension of planning a roadmap and navigating the device to the desired location. After device selection and determination of its optimal position, the procedure roadmap is ready and the device can be inserted and advanced. Under fluoroscopy, the system detects the device and presents its position in relation to the roadmap. Once the device has reached its predetermined position, the Guidance indicates "Device in Position" and the physician can proceed with deployment of the delivered device.

• Penumbra (Alameda, California) reported clinical results of the Penumbra POST stroke study. In this study, all patients reviewed had presentation characteristics that were consistent with acute ischemic stroke including NIH Stroke Scale (NIHSS) score 8, presentation within 8 hours of symptom onset, and a complete or near-complete (TIMI grade 0 or I) occlusion of a large intracranial vessel. The Penumbra system is a package of tools used by neurointerventional specialists to remove clots from the large vessels of the brain that are causing a stroke. It works on the proximal surface of the occlusion, optimizing safety and eliminating the need for navigation beyond the clot. The Penumbra system is comprised of an aspiration platform containing multiple devices that are size-matched to the specific neurovascular anatomy, allowing clots to be gently aspirated out of intracranial vessels.

No Comments